Skip to main content
Log in

Alemtuzumab

Graves-orbitopathy

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Rodriguez de Vera GomezP, et al. Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis. Journal of Neurology 271 : 486-496, Sep 2023. Available from: URL: https://dx.doi.org/10.1007/s00415-023-11995-6

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 2002, 28 (2024). https://doi.org/10.1007/s40278-024-55405-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-55405-3

Navigation